Parasites, Hosts and Diseases
- Volume 39 Issue 1
- /
- Pages.67-76
- /
- 2001
- /
- 2982-5164(pISSN)
- /
- 1738-0006(eISSN)
Toxoplasma gondii: Ultrastructural localization of specific antigens and inhibition of intracellular multiplication by monoclonal antibodies
- Lee, Boo-Young (Department of Parasitology, Institute of Biomedical Science, Hanyang University College of Medicine) ;
-
Ahn, Myoung-Hee
(Department of Parasitology, Institute of Biomedical Science, Hanyang University College of Medicine) ;
- Kim, Hyun-Chul (Department of Parasitology, Institute of Biomedical Science, Hanyang University College of Medicine) ;
-
Min, Duk-Young
(Department of Parasitology, Institute of Biomedical Science, Hanyang University College of Medicine)
- Published : 2001.03.01
Abstract
This experiment was focused on the characterization of anti- Toxoplasma monoclonal antibodies (mAbs) and the effect of mAbs on the parasite invasion of mouse peritoneal macrophages. Twenty eight mAbs including M110, M556, R7A6 and M62l were characterized by Ab titer, immunoglobulin isotyping and western blot pattern. Antibody titer (optical density) of 4 mAbs. Ml 10. M556. R7A6 and M62l. were 0.53,0.67, 0.45 and 0.39 (normal mouse serum; 0.19) with the same IgGl isotypes shown by Enzyme-linked immunosorbent assay (ELISA). Western blot analysis showed that Ml 10. M556. R7A6 and M62l reacted with the 33 kDa (p30),31 kDa (p28),43 kDa and 36 kDa protein. Immuno-gold labelling of mAbs M110, M556, R7A6 and M621 reacted with the surface membrane, dense granules and parasitophorous vacuolar membrane (PVM) , rhoptries and cytoplasm of tachyzoite, respectively. For in vitro assay, preincubation of tachyzoties with four mAbs, Ml 10, M556, R7A6 and M62l resulted in the decrease of the number of infected macrophages (p < 0.05) and the suppression of parasite multiplication at 18 h post-infection. Four monoclonal antibodies including Ml 10 (SAGI) were found to have an important role in the inhibition of macrophage invasion and T. gondii multiplication in vitro, and these mAbs may be suitable for vaccine candidates, diagnostic kit and for chemotherapy.